ReviewJournal of virology2026
Mapping the monoclonal antibody landscape of human cytomegalovirus.
Review in Journal of virology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Comparative evaluation of screening approaches for antiviral monoclonal antibody combinations.Journal of virology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Human cytomegalovirus (HCMV) is a major cause of congenital disease and a significant threat to immunocompromised individuals, particularly transplant recipients and neonates. Over the past five decades, numerous monoclonal antibodies (mAbs) targeting various HCMV antigens have been isolated. Here, we present a comprehensive review of HCMV-specific mAbs isolated from the 1980s to the present, detailing their target antigens, epitopes, neutralizing activity, and potential clinical applications. This review integrates historical discoveries with recent structural and functional studies, highlighting trends that may inform the development of anti-HCMV therapeutics and prophylactics.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.